Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Basu K et al. – The Arg16 genotype of ADRB2 is associated with exacerbations in asthmatic children and young adults exposed daily to beta2–agonists, regardless of whether the exposure is to albuterol or long–acting agonists, such as salmeterol.

Related Articles

Beta2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate
American Journal of Respiratory and Critical Care Medicine, 11/17/09    Relevance Score: 87%

Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09    Relevance Score: 85%

Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate
Chest, 10/20/09    Relevance Score: 84%

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Cochrane Reviews, 10/20/09    Relevance Score: 84%

Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges
Current Medical Research and Opinion, 10/19/09    Relevance Score: 80%

Today in Asthma/Atopy...keeping you current

Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men
The Clinical Respiratory Journal, 12/16/09

The effect of statin therapy on allergic patients with asthma
Annals of Allergy, Asthma, and Immunology, 12/16/09

Asthma Research Performance in Asia-Pacific: A Bibliometric Analysis by Searching PubMed Database
Journal of Asthma, 12/16/09

Today in Clinical Pharmacology...keeping you current

Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09

Use of oseltamivir in children
Canadian Family Physician, 12/16/09

Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address